Integral Ad Science (NASDAQ:IAS – Free Report) had its price objective trimmed by Craig Hallum from $18.00 to $16.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has a buy rating on the stock.
Several other research analysts also recently commented on IAS. Raymond James boosted their target price on Integral Ad Science from $13.00 to $15.00 and gave the stock an “outperform” rating in a research note on Friday, August 2nd. Morgan Stanley upped their price objective on shares of Integral Ad Science from $12.00 to $13.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 23rd. Oppenheimer cut their target price on shares of Integral Ad Science from $20.00 to $18.00 and set an “outperform” rating on the stock in a research report on Wednesday. Benchmark reiterated a “hold” rating on shares of Integral Ad Science in a report on Monday, August 5th. Finally, Barclays increased their price target on Integral Ad Science from $12.00 to $13.00 and gave the company an “equal weight” rating in a research note on Monday, August 5th. Three analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $15.70.
Read Our Latest Stock Report on Integral Ad Science
Integral Ad Science Price Performance
Integral Ad Science (NASDAQ:IAS – Get Free Report) last released its earnings results on Tuesday, November 12th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.02. Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. The firm had revenue of $133.50 million during the quarter, compared to analysts’ expectations of $138.06 million. During the same period in the prior year, the company earned ($0.09) earnings per share. The company’s quarterly revenue was up 11.0% on a year-over-year basis. On average, equities research analysts predict that Integral Ad Science will post 0.26 EPS for the current fiscal year.
Insider Buying and Selling at Integral Ad Science
In other news, CEO Lisa Utzschneider sold 10,481 shares of Integral Ad Science stock in a transaction dated Monday, October 7th. The stock was sold at an average price of $10.11, for a total value of $105,962.91. Following the completion of the transaction, the chief executive officer now directly owns 239,709 shares of the company’s stock, valued at approximately $2,423,457.99. This trade represents a 4.19 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Tania Secor sold 5,240 shares of the business’s stock in a transaction dated Monday, October 7th. The shares were sold at an average price of $10.11, for a total value of $52,976.40. Following the completion of the transaction, the chief financial officer now directly owns 248,223 shares in the company, valued at $2,509,534.53. This represents a 2.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 23,006 shares of company stock valued at $240,296. 2.00% of the stock is currently owned by company insiders.
Institutional Trading of Integral Ad Science
Several hedge funds have recently modified their holdings of IAS. Geode Capital Management LLC boosted its holdings in Integral Ad Science by 6.4% in the third quarter. Geode Capital Management LLC now owns 1,834,659 shares of the company’s stock worth $19,836,000 after acquiring an additional 110,149 shares in the last quarter. Barclays PLC increased its position in shares of Integral Ad Science by 207.1% during the third quarter. Barclays PLC now owns 127,733 shares of the company’s stock worth $1,380,000 after acquiring an additional 86,133 shares in the last quarter. Public Employees Retirement System of Ohio acquired a new stake in shares of Integral Ad Science in the 3rd quarter worth about $138,000. Washington Harbour Partners LP bought a new stake in Integral Ad Science during the 3rd quarter worth approximately $1,744,000. Finally, Repertoire Partners LP bought a new position in shares of Integral Ad Science in the third quarter valued at approximately $1,676,000. Institutional investors own 95.78% of the company’s stock.
About Integral Ad Science
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Featured Articles
- Five stocks we like better than Integral Ad Science
- Investing in Commodities: What Are They? How to Invest in Them
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Stock Analyst Ratings and Canadian Analyst Ratings
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Manufacturing Stocks Investing
- Time to Load Up on Home Builders?
Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.